Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multi-center, Observational, Drug-utilization Study in Belgium to Evaluate the Use of VIMPAT in Clinical Practice as Adjunctive Treatment of Partial Onset Epilepsy in Subjects Aged 16 and Older.

Next Previous
Trial Profile

Multi-center, Observational, Drug-utilization Study in Belgium to Evaluate the Use of VIMPAT in Clinical Practice as Adjunctive Treatment of Partial Onset Epilepsy in Subjects Aged 16 and Older.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Oct 2014

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lacosamide (Primary)
  • Indications Partial epilepsies
  • Focus Therapeutic Use
  • Sponsors UCB

Most Recent Events

  • 02 May 2012 Actual patient number changed from 109 to 192 as reported by ClinicalTrials.gov.
  • 23 Apr 2012 Actual patient number added 190 according to ClinicalTrials.gov.
  • 23 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top